A new study has found that many women with early-stage breast cancer can receive a lower or more targeted dose of radiotherapy after surgical removal of their tumors, reducing side-effects with no negative impact on their chance of survival.
The results of the research which involved over two-thousand women with breast cancer across 71 treatment centers in the U.K. was published in the Journal of Clinical Oncology and funded by Cancer Research U.K.